2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane
C25H33ClN4OS — CID 170953967
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane
2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane (PubChem CID 170953967) has the molecular formula C25H33ClN4OS and a molecular weight of 473.09 g/mol. Its IUPAC name is 2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane.
Molecular Properties
| Compound Name | 2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane |
|---|---|
| PubChem CID | 170953967 |
| Molecular Formula | C25H33ClN4OS |
| Molecular Weight | 473.09 g/mol |
| Exact Mass | 472.21 |
| IUPAC Name | 2-(4-tert-butylsulfanyl-2-methylanilino)-6-chloro-8-cyclopentylpyrido[2,3-d]pyrimidin-7-one;ethane |
| SMILES | CC.Cc1cc(SC(C)(C)C)ccc1Nc1ncc2cc(Cl)c(=O)n(C3CCCC3)c2n1 |
| InChI | InChI=1S/C23H27ClN4OS.C2H6/c1-14-11-17(30-23(2,3)4)9-10-19(14)26-22-25-13-15-12-18(24)21(29)28(20(15)27-22)16-7-5-6-8-16;1-2/h9-13,16H,5-8H2,1-4H3,(H,25,26,27);1-2H3 |
| InChIKey | ZKBSMNYDXNKPSK-UHFFFAOYSA-N |
| XLogP | 7.53 |
| TPSA | 59.81 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.09 |
| LogP ≤ 5 | 7.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170953967 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.